Technical Outlook And Game Plan For Regeneron Pharmaceuticals, Inc (NASDAQ: REGN)
Regeneron Pharmaceuticals, Inc (REGN) concluded trading on Thursday at a closing price of $547.36, with 0.46 million shares of worth about $249.81 million changed hands